Navigation Links
New York-Based Sanders Law Firm Files Five Product Liability Lawsuits Against Pfizer on Behalf of Chantix™ Plaintiffs
Date:8/5/2008

Leading personal injury law firm representing families of individuals who suffered from suicidal thoughts and erratic behavior while taking popular smoking cessation drug

Mineola, N.Y. (Lexis Nexis) August 5, 2008 - http://thesandersfirm.com/attorney.asp?attorneyid=14 [Marc Grossman], senior partner of leading national personal injury law firm Sanders Viener Grossman LLP, today announced that he has filed five separate product liability lawsuits against Pfizer, Inc., manufacturer of the hugely popular Chantix smoking cessation drug.

The lawsuits (Cases 110517/08, 110518/08, 110519/08, 110520/08 and 110561/08) were filed in the Supreme Court of New York, New York County, and claim that each of the plaintiffs either committed or attempted suicide while suffering from neuropsychiatric side effects that resulted from taking Chantix.

Chantix has been prescribed to more than 6 million people worldwide since its launch in August 2006 and has been approved for use in more than 70 countries as a drug to assist adults who want to quit smoking. However, recent studies have shown that http://thesandersfirm.com/chantix/ [Chantix] may cause serious adverse side effects, such as suicidal thoughts and erratic behavior.

Earlier this year, the U.S. Food and Drug Administration (FDA) issued an alert "to highlight important revisions to the warnings and precautions sections of the prescribing information for Chantix regarding serious neuropsychiatric symptoms."

"We've been investigating claims regarding Chantix ever since the FDA's initial communications about reported side effects, so our firm was well-prepared to vigorously represent our clients when we were contacted by their families," said Grossman. "For those familiar with this year's Tony Award-winning play, 'August: Osage County,' which has sparked debate about the risks of suicide and dysfunction stemming from prescription drug use, the fact that we are filing these actions on the eve of August 1st is a tragic illustration of life imitating art."

The filing of the Chantix lawsuits continues an extremely active year for Sanders Viener Grossman, in which the firm has secured a series of large settlements on behalf of its clients. The firm recently recovered large settlements for approximately 300 plaintiffs involved in the Vioxx-related litigation with Merck & Co. Last month, Sanders Viener Grossman recovered http://thesandersfirm.com/news.asp#article2 [$8 million in damages] for its clients over a span of just eight days, including a $5 million recovery in a product liability case.

According to Grossman, the firm has extensive experience with defective drug litigation and can provide Chantix victims with free consultations and http://thesandersfirm.com/chantix/#form [case reviews] to make sure their legal rights are protected.

For more information about Sanders Viener Grossman LLP, please visit www.thesandersfirm.com or call 1.800.FAIRPLAY.

###

Read the full story at http://www.prweb.com/releases/2008/08/prweb1140624.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Sanderson Farms Launches New Summer Program Encouraging Families to Get Healthy
2. Home Oxygen Community Applauds Senator Bernard Sanders for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
3. DNA Testing and Genetic Profiles Help Avoid Broken Hearts Polls Reveal
4. Sunrise Files 2007 Form 10-K
5. AutoGenomics, Inc. Files Registration Statement for Initial Public Offering
6. Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court
7. The Quantum Group Files TPA Application
8. Noesis Health Introduces AdvancedSMAT for Better Management of Cloverleaf Message Files
9. MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada
10. VNUS Medical Technologies, Inc. Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch
11. Sangui BioTech Files Three 2007 Quarterly Reports, Sales Increased, Losses Continue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ANGELES (PRWEB) , ... October 12, 2017 , ... ... Parsa Mohebi Hair Restoration, has recently contributed a medical article to the newly ... on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... and other leading institutions in announcing the launch of the Leadership Circle ... way animals are raised for food. , Founding members of the Leadership Circle ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
(Date:10/2/2017)... 2, 2017 Halo Labs announces the European launch of ... the HORIZON at MIBio 2017 in Cambridge, U.K ... particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity while ... technique Backgrounded Membrane Imaging. ... HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
Breaking Medicine Technology: